Case Study Analysis

Marcus, a 16-year-old black male, has acute joint pain, chest pain, fatigue, scleral icterus, and shortness of breath, which are the typical symptoms of sickle cell anemia. The cellular and genetic mechanism of this disease should be comprehended in order to influence the way treatment is conducted as well as to increase adherence in adolescent patients. Such points covered by this review are pathophysiologic processes, genetic defects that are mutational in nature, immune dysfunction, the present treatment, including hydroxyurea, and the cultural adaptation of a patient-education program: Case Study Analysis.

Pathophysiology and Symptom Correlation

Sickle cell disease (SCD) is an illness caused by the synthesis of abnormal hemoglobin S (HbS) that clumps in low oxygen levels with subsequent sickling of the red blood cells (RBCs). The deformed cells become rigid and adhesive, which causes a blockage of the vasculature and multiple failures of oxygen delivery, according to Mangla et al. (2020). Tissue anemia and ischemia are the reasons behind the excruciating pain (vaso-occlusive crisis), fatigue, and shortness of breath that Marcus describes.

His high reticulocyte count and LDH indicate a compensatory response of the bone marrow to hemolysis, whereas the pale conjunctiva and the hemoglobin of 7.1 g/dL indicate the presence of significant anemia. Scleral icterus is caused by the deposition of bilirubin as a result of increased RBC breakdown, once again indicating the hemolytic nature of SCD.

Genetic Mutation and Inheritance

The etiology of SCD is based on a point mutation in the gene of β-globin (HBB) on the 11th chromosome, and the glutamic acid in position six is replaced by valine. Lattanzi et al. (2021) assert that this GAG →GTG single-nucleotide polymorphism causes the HbS condition. It has an autosomal recessive mode of inheritance; both genes must be mutated in order to have clinical diseases.

Marcus is a carrier of the HbS gene obtained as a legacy of his genetic mother and, most likely, of his unknown genetic father. Such a family history highlights the point of family screening and counseling.

Immune System Implications

SCD has an impact on immune function because splenic infarction and functional asplenia cause a very high risk of bacterial infections with encapsulated pathogens, including Streptococcus pneumoniae and Haemophilus influenzae (Peretz et al., 2022). Such vulnerability may be reflected in the fact that Marcus was repeatedly hospitalized with low-grade fever. Immune dysregulation and disease complications are further undermined by endothelial dysfunction and long-term inflammation.

Therapeutic Mechanisms of Hydroxyurea

The first-line treatment of SCD is disease-modifying therapy, hydroxyurea. It acts by stimulating the production of fetal hemoglobin (HbF), which is able to prevent the polymerization of HbS and sickling. It also decreases the number of white blood cells and expression levels of adhesion molecules, decreasing the possibility of vaso-occlusion and inflammation, as described by Kavanagh et al. (2022).

These positive effects have been reduced by Marcus’ inconsistent treatment and most likely lead to a relapse and rise in the number of his crises. Excessive therapy is essential to minimize morbidity and enhance the quality of life.

Culturally Sensitive Education for Treatment Adherence

As an adolescent African American male with a chronic disease, Marcus may have cultural, socioeconomic, and developmental concerns to follow treatment. Berry et al. (2024) recommend that the APRN should provide developmentally appropriate, culturally sensitive education through shared decision-making, peer support interventions, and electronic reminders to facilitate adherence. Topics of discussion should include stigma, fear of medications, and the importance of routine care. Involving family and possibly matching Marcus with African American mentors who also have SCD can facilitate positive adaptation and self-management of treatment.

Conclusion

The presentation of Marcus is typical of classic features of SCD, triggered by a genetic mutation leading to hemolytic anemia, vaso-occlusion, and immune dysfunction. Hydroxyurea remains the cornerstone therapy, targeting fundamental cellular pathology. Effective APRN practice must also integrate culturally relevant education techniques to facilitate adolescent adherence and chronic disease management.

References

Berry, J. A., Cranford, J., & Powell, R. (2024). The Stress of Advancement: A Nurse Practitioner’s Exploration in Providing Culturally Competent Obesity Prevention Counseling in Black Women. Health Promotion Practice. https://doi.org/10.1177/15248399231221767

Kavanagh, P. L., Fasipe, T. A., & Wun, T. (2022). Sickle Cell Disease. JAMA, 328(1), 57. https://doi.org/10.1001/jama.2022.10233

Lattanzi, A., Camarena, J., Lahiri, P., Segal, H., Srifa, W., Vakulskas, C. A., Frock, R. L., Kenrick, J., Lee, C., Talbott, N., Skowronski, J., Cromer, M. K., Charlesworth, C. T., Bak, R. O., Mantri, S., Bao, G., DiGiusto, D., Tisdale, J., Wright, J. F., & Bhatia, N. (2021). Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease. Science Translational Medicine, 13(598), eabf2444. https://doi.org/10.1126/scitranslmed.abf2444

Mangla, A., Ehsan, M., & Maruvada, S. (2020). Sickle Cell Anemia. PubMed; StatPearls Publishing. https://pubmed.ncbi.nlm.nih.gov/29489205/

Peretz, S., Livshits, L., Pretorius, E., Makhro, A., Bogdanova, A., Gassmann, M., Koren, A., & Levin, C. (2022). The protective effect of the spleen in sickle cell patients. A comparative study between patients with asplenia/hyposplenism and hypersplenism. Frontiers in Physiology, 13. https://doi.org/10.3389/fphys.2022.796837

ORDER A PLAGIARISM-FREE PAPER HERE

We’ll write everything from scratch

An understanding of cells and cell behavior is a critically important component of disease diagnosis and treatment. But some diseases can be complex in nature, with a variety of factors and circumstances impacting their emergence and severity.

Effective disease analysis often requires an understanding that goes beyond isolated cell behavior. Genes, the environments in which cell processes operate, the impact of patient characteristics, and racial and ethnic variables all can have an important impact.

An understanding of the signals and symptoms of alterations in cellular processes is a critical step in the diagnosis and treatment of many diseases. For APRNs, this understanding can also help educate patients and guide them through their treatment plans.

In this Assignment, you examine a case study and analyze the symptoms presented. In 1-2 pages, you will answer the questions provided following the case scenario. You must use current evidence-based resources to support your answers. Follow APA guidelines. Follow the grading rubric.

Case Study Analysis

Resources

• Be sure to review the Learning Resources before completing this activity.
• Click the weekly resources link to access the resources. (SEE ATTACHED)

To prepare:

• By Day 1 of this week, you will be assigned to a specific case study for this Case Study Assignment. Please see the “Announcements” section of the classroom for your assignment from your Instructor.

The Assignment

• Develop a 1- to 2-page case study analysis by answering the questions provided following the case scenario.

Reminder: The College of Nursing requires that all papers submitted include a title page, introduction, summary, and references. The sample paper provided at the Walden Writing Center provides an example of those required elements (available at https://academicguides.waldenu.edu/writingcenter/templatesLinks to an external site.). All papers submitted must use this formatting.